Список проголосовавших за комментарий " On The Wires<ul><li>Abeona Therapeutics Inc. (<strong>ABEO</strong>) announced that the first high-dose subject was enrolled in the ongoing Phase 1/2 trial for ABO-102 (AAV-SGSH). The first-in-man clinical trial utilizes a single intravenous injection of AAV gene therapy for patients with MPS IIIA (Sanfilippo syndrome type A), a devastating lysosomal storage disease that affects every cell and organ resulting in neurocognitive decline, speech loss, loss of mobility, and premature death.</li><li>Jacobs Engineering Group Inc. (<strong>JEC</strong>) has been awarded a two-year contract by Transport for London to provide integrated impact assessment services to support development and finalization of the revised Mayor's Transport Strategy (MTS) for London, United Kingdom. The MTS is one of the key plans for the incoming Mayor of London to establish its refreshed policy framework and strategic direction for London's transport to meet projected economic and population growth. TfL is responsible for most aspects of London's transport system. Financial details were not disclosed. </li></ul>"